Integrated Wealth Concepts’s TG Therapeutics TGTX Stock Holding History

Integrated Wealth Concepts’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.2M	Sell	21,754 -46	-0.2%	-$1.88K	0.01%	1106
2026 Q1	$724K	Buy	+21,800	New	+$650K	0.01%	1301
2025 Q4	–	Sell	-21,960	Closed	-$793K	–	2011
2025 Q3	$793K	Buy	21,960 +15,675	+249%	+$516K	0.01%	1108
2025 Q2	$226K	Buy	+6,285	New	+$234K	﹤0.01%	1701
2021 Q4	–	Sell	-6,398	Closed	-$213K	–	1020
2021 Q3	$213K	Buy	+6,398	New	+$198K	0.01%	874

Other funds holding TGTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Integrated Wealth Concepts's TGTX Position: Q2 2026 in Review

Integrated Wealth Concepts reduced its TG Therapeutics (TGTX) stake by 0.21% in Q2 2026, selling an estimated $1.88K and leaving 21,754 shares worth $1.2M. The position accounts for 0.01% of the portfolio, ranked #1106.

Integrated Wealth Concepts first reported a position in TGTX in Q3 2021 and has held it in 5 quarters since. 430 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

Integrated Wealth Concepts held 21,754 shares of TG Therapeutics worth $1.2M as of Q2 2026.
Integrated Wealth Concepts sold 46 TG Therapeutics shares in Q2 2026, an estimated $1.88K.
TG Therapeutics made up 0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #1106 holding.
Integrated Wealth Concepts first reported a position in TG Therapeutics in Q3 2021 and has held it in 5 quarters since.
430 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.